Acorda Therapeutics reported $22.25M in Gross Profit on Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 112.52M 15.68M
Acorda Therapeutics ACOR:US $ 22.25M 5.68M
Agios Pharmaceuticals AGIO:US $ 5.15M 4.65M
ALKERMES ALKS:US 217.86M 5.53M
Amgen AMGN:US $ 5084M 407M
Anika Therapeutics ANIK:US $ 24.86M 3.06M
Biogen BIIB:US $ 2105.1M 327.2M
Biomarin Pharmaceutical BMRN:US $ 410.67M 8.28M
Clovis Oncology CLVS:US $ 24.83M 1.4M
Gilead Sciences GILD:US $ 4818M 348M
GlaxoSmithKline GSK:LN 4.79B 1.34B
Halozyme Therapeutics HALO:US $ 101.36M 20.94M
Heron Therapeutics HRTX:US $ 12.1M 2.39M
Insmed INSM:US $ 48.83M 7.91M
Ligand Pharmaceuticals LGND:US $ 40.99M 19.5M
Mannkind MNKD:US $ 0.99M 0.09M
Moderna Inc MRNA:US 3.37B 1.68B
Neurocrine Biosciences NBIX:US $ 373.4M 67.4M
Novartis NOVN:VX 9.34B 277M
Pfizer PFE:US $ 19071M 3420M
Teva Pharmaceutical TEVA:IT 1.83B 26M
Ultragenyx Pharmaceutical RARE:US $ 81.07M 7.24M
Vertex Pharmaceuticals VRTX:US $ 1934.4M 82.7M